Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Debt to Equity (2016 - 2026)

Cryo Cell International's Debt to Equity history spans 17 years, with the latest figure at -$0.13 for Q1 2026.

  • Quarterly results put Debt to Equity at -$0.13 for Q1 2026, up 63.79% from a year ago — trailing twelve months through Feb 2026 was -$0.13 (up 63.79% YoY), and the annual figure for FY2025 was -$0.17, up 80.94%.
  • Debt to Equity for Q1 2026 was -$0.13 at Cryo Cell International, up from -$0.17 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.21 in Q1 2022 to a low of -$222.59 in Q3 2023.
  • The 5-year median for Debt to Equity is -$0.48 (2025), against an average of -$14.91.
  • The sharpest move saw Debt to Equity surged 143.59% in 2022, then plummeted 6130.9% in 2023.
  • Year by year, Debt to Equity stood at -$7.12 in 2022, then surged by 97.33% to -$0.19 in 2023, then plummeted by 370.72% to -$0.9 in 2024, then skyrocketed by 80.94% to -$0.17 in 2025, then rose by 21.18% to -$0.13 in 2026.
  • According to Business Quant data, Debt to Equity over the past three periods came in at -$0.13, -$0.17, and -$0.77 for Q1 2026, Q4 2025, and Q3 2025 respectively.